AstraZeneca
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell AstraZeneca and other ETFs, options, and stocks.About AZN
AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company’s history roots back to the year 1913 when Astra business was formed.
AZN Key Statistics
AZN News
AstraZeneca PLC AZN and its Japan-based partner Daiichi Sankyo announced that the FDA has approved their blockbuster antibody-drug conjugate (ADC), Enhertu, for...
Below is Validea's guru fundamental report for ASTRAZENECA PLC (ADR) (AZN). Of the 22 guru strategies we follow, AZN rates highest using our P/B Growth Investor...
On Monday, AstraZeneca Plc (NASDAQ:AZN) released topline data from the LATIFY Phase 3 trial of ceralasertib in combination with Imfinzi (durvalumab). The trial...
Analyst ratings
81%
of 32 ratingsMore AZN News
AstraZeneca (AZN) announced an update on their ongoing clinical study. Claim 50% Off TipRanks Premium and Invest with Confidence Unlock hedge-fund level data...
AstraZeneca (AZN) announced an update on their ongoing clinical study. Claim 70% Off TipRanks This Holiday Season AstraZeneca Explores CAR-T for Autoimmune Di...
The FDA said in a statement: “Since approval, the FDA has received postmarketing safety data on thromboembolic events, including serious and fatal outcomes, in...
The U.S. Food and Drug Administration (FDA) said the safety risks associated with Andexxa now outweigh its benefits, prompting AstraZeneca Plc (NASDAQ:AZN) to s...
Claim 50% Off TipRanks Premium and Invest with Confidence Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper...
AstraZeneca’s (AZN) breast cancer drug Enhertu has been granted Breakthrough Therapy Designation by the U.S. Food and Drug Administration (FDA). The FDA gave th...
The first patient has been dosed in the DESTINY-Endometrial02 phase 3 trial evaluating Enhertu with or without radiotherapy compared to standard of care chemoth...